series-c-plus
Stage
About
REGENHU SA is a Swiss medtech company that develops and manufactures 3D bioprinting instruments and accompanying software (R-GEN series and SHAPER) for creating tissue models, human skin equivalents, tablet formulations, and cellular models for drug discovery. Their platforms combine multiple printing technologies to support biofabrication, personalized medicine development, and pharmaceutical R&D applications.
Explore REGENHU SA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.